share_log

Jazz Pharmaceuticals | 10-K/A: Annual report (Amendment)

SEC ·  May 2, 2022 16:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more